Altria Group, Inc. ranks tenth in the list of best long-term investments for kids. FDA granted marketing authorization on December 21, 2025, for six on! PLUS nicotine pouch products manufactured by MO’s subsidiary, Helix Innovations LLC. This approval supports Altria’s strategy to move beyond smoking with differentiated products against rivals like ZYN. BofA Securities analyst Lisa Lewandowski lowered the price target for MO to $64 from $66 citing evolving consumer trends and pressure from the illicit e-vapor market. Altria Group, Inc. is a major American tobacco and nicotine products company known for brands like Marlboro cigarettes and Copenhagen smokeless products. AI stocks may offer greater upside potential and less downside risk compared to MO as an investment.

Read more at Yahoo Finance: Goldman Sees Growth Catalyst for Altria Group, Inc. (MO) After FDA Approval of on! PLUS